Literature DB >> 15061256

Clinical outcome and plasma levels of clozapine and norclozapine in drug-resistant schizophrenic patients.

Massimo Mauri, Lucia S Volonteri, Alessio Fiorentini, Giordano Invernizzi, Teresa Nerini, Marialuisa Baldi, Silvio R Bareggi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15061256     DOI： 10.1016/s0920-9964(03)00159-2

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  9 in total

Review 1.  Predictors and markers of clozapine response.

Authors:  Carmen Chung; Gary Remington
Journal:  Psychopharmacology (Berl)       Date:  2005-02-17       Impact factor: 4.530

Review 2.  Clinical Pharmacokinetics of Atypical Antipsychotics: An Update.

Authors:  Massimo Carlo Mauri; Silvia Paletta; Chiara Di Pace; Alessandra Reggiori; Giovanna Cirnigliaro; Isabel Valli; Alfredo Carlo Altamura
Journal:  Clin Pharmacokinet       Date:  2018-12       Impact factor: 6.447

3.  Genetic and Clinical Factors Affecting Plasma Clozapine Concentration.

Authors:  Eric Olsson; Gunnar Edman; Leif Bertilsson; Dzana Sudic Hukic; Catharina Lavebratt; Sven V Eriksson; Urban Ösby
Journal:  Prim Care Companion CNS Disord       Date:  2015-02-19

Review 4.  Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response.

Authors:  Massimo C Mauri; Lucia S Volonteri; Alessandro Colasanti; Alessio Fiorentini; Ilaria F De Gaspari; Silvio R Bareggi
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 5.  Upcoming agents for the treatment of schizophrenia: mechanism of action, efficacy and tolerability.

Authors:  Delia Bishara; David Taylor
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 6.  Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?

Authors:  Gary Remington; Ofer Agid; George Foussias; Larissa Ferguson; Krysta McDonald; Valerie Powell
Journal:  Psychopharmacology (Berl)       Date:  2012-11-22       Impact factor: 4.530

7.  Outcomes in treatment-resistant schizophrenia: symptoms, function and clozapine plasma concentrations.

Authors:  Amir Krivoy; Eromona Whiskey; Henrietta Webb-Wilson; Dan Joyce; Derek K Tracy; Fiona Gaughran; James H MacCabe; Sukhwinder S Shergill
Journal:  Ther Adv Psychopharmacol       Date:  2021-10-16

Review 8.  Clinical pharmacology of atypical antipsychotics: an update.

Authors:  M C Mauri; S Paletta; M Maffini; A Colasanti; F Dragogna; C Di Pace; A C Altamura
Journal:  EXCLI J       Date:  2014-10-13       Impact factor: 4.068

9.  Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine.

Authors:  Yoshiyuki Tsuda; Junji Saruwatari; Norio Yasui-Furukori
Journal:  BMJ Open       Date:  2014-03-04       Impact factor: 2.692
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.